Medication Guide

Ozempic Side Effects: Nausea, Timeline & Warnings (2026)

By HAVIT Editorial TeamReviewed by HAVIT Medical Advisory · Editorial Medical Review Board
Updated 2026-07-02· 9 min read

This article is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition.

Quick answer

Ozempic's most common side effects are gastrointestinal — nausea, vomiting, diarrhea, constipation, and abdominal pain — usually mild and worst during dose increases. Rare but serious risks include pancreatitis, gallbladder disease, and severe delayed stomach emptying, which need urgent care.

Ozempic is the brand name for semaglutide, a once-weekly injectable GLP-1 receptor agonist approved by the FDA for type 2 diabetes (and to reduce cardiovascular risk in adults with type 2 diabetes and heart disease).

It is the same molecule found in Wegovy — just at a different maximum dose and for a different approved use, a nuance we cover below.

Semaglutide works largely by slowing how fast the stomach empties and by acting on appetite centers in the brain.

That mechanism is exactly why the most common Ozempic side effects are digestive.

This page is a drug-specific deep-dive; for the whole class, see our GLP-1 side effects hub.

01

The most common Ozempic side effects

In placebo-controlled trials, gastrointestinal reactions were the most frequently reported Ozempic side effects, and they were clearly dose-related. According to the FDA-approved Ozempic label, the reactions occurring in ≥5% of patients were nausea, vomiting, diarrhea, abdominal pain, and constipation.

The label reports the following incidence versus placebo (pooled 0.5 mg and 1 mg data):

(Source: FDA Ozempic prescribing information. Ozempic also has a 2 mg maintenance dose; individual experience varies.)

Crucially, the label notes that most reports of nausea, vomiting, and diarrhea occurred during dose escalation — the weeks when the dose is being stepped up.

Ozempic nausea

Nausea is the single most common Ozempic side effect. It typically peaks in the first one to three days after a dose or a dose increase, then settles as your body adjusts.

Practical strategies widely recommended by clinics such as Cleveland Clinic: eat smaller, more frequent meals, eat slowly and stop at the first feeling of fullness, favor bland, low-fat foods, and sip fluids between meals rather than with them.

Greasy, fried, and very sweet foods tend to make Ozempic nausea worse.

If nausea is disruptive, some clinicians prescribe a short course of an anti-nausea medicine around dose increases. (Deep-dive: how to manage GLP-1 nausea.)

Vomiting and diarrhea

Vomiting and diarrhea are less common than nausea but can cause a real problem: dehydration. Because Ozempic can also blunt thirst and appetite, it is easy to under-drink.

Persistent vomiting or diarrhea that keeps you from holding down fluids is a reason to call your clinician — partly because severe dehydration can, in rare cases, trigger acute kidney injury (see serious effects below).

Constipation

Constipation stems from the same slowed gut motility that drives the drug's effect. Standard measures — more fiber, adequate fluids, and regular movement — usually help.

Constipation with severe cramping, bloating, and vomiting, however, can signal a bowel obstruction and should be evaluated.

Other common effects

People also report burping, heartburn, gas, fatigue, headache, dizziness, and injection-site reactions (redness or itching at the injection spot). These are usually mild.

Hair thinning is sometimes reported, but with Ozempic it is generally attributed to rapid weight change rather than a direct drug effect, and it is usually temporary.

02

How long do Ozempic side effects last?

For most people, the common gastrointestinal side effects are temporary. Nausea and related symptoms most often ease within about 2 to 4 weeks of starting Ozempic or of each dose increase, as the body adjusts — a pattern Cleveland Clinic describes as typical for GLP-1 medicines.

Because side effects cluster around dose changes, a slow, gradual dose escalation is the single most effective way to limit them, which is why the manufacturer builds in a multi-week titration schedule that begins at a low, non-therapeutic starter dose.

If a side effect is still severe after four weeks, or you are losing weight faster than intended, that is a signal to talk with your prescriber.

They may hold your dose at its current step longer or reduce it. Do not adjust your own dose without medical guidance.

03

"Ozempic face": what it really is

"Ozempic face" is a media/social term, not a medical diagnosis — Cleveland Clinic describes it as gauntness, sunken cheeks, new wrinkles, and loose skin on the face and neck.

It is not a toxic effect of the drug. It is the visible result of rapid fat loss: facial fat pads that support the cheeks, temples, and jawline shrink, and skin that loses its underlying volume can fold or sag.

The same change can follow any fast weight loss, including bariatric surgery.

Because the driver is the pace of weight loss, Cleveland Clinic's prevention advice centers on losing weight more gradually, eating enough protein to preserve muscle, and staying hydrated to help skin elasticity.

Dermatologic options (fillers, collagen-stimulating treatments) exist for those who want them, but they are cosmetic, not medical necessities.

04

Dose-dependence and titration: why the ramp-up matters

Ozempic side effects are strongly dose-dependent — the label's own numbers show more nausea and vomiting at 1 mg than at 0.5 mg.

This is the reason the prescribing information uses a stepwise titration rather than starting at a full dose.

The most reliable predictor of how you will tolerate Ozempic is how quickly the dose is increased, not any personal "toughness." If a step is hard, prescribers can slow the ramp, which is a decision for your clinician, not a self-adjustment.

05

Serious Ozempic side effects and warnings

These are less common but important, and they are why Ozempic is prescription-only and medically supervised.

Pancreatitis

The Ozempic label warns that acute pancreatitis has occurred.

The classic sign is severe, persistent abdominal pain — often in the upper abdomen, sometimes radiating to the back — with or without vomiting.

Manufacturer guidance is explicit: stop the medicine and seek care promptly. If pancreatitis is confirmed, Ozempic should not be restarted.

Gallbladder problems and gallstones

The label warns of gallbladder disease, including gallstones (cholelithiasis), some requiring surgery.

Warning signs include pain in the upper-right abdomen, fever, yellowing of the skin or eyes (jaundice), and clay-colored stools.

Delayed gastric emptying, gastroparesis, and aspiration risk

Ozempic slows stomach emptying by design, but in some people this becomes problematic.

The FDA added delayed gastric emptying to semaglutide labeling, and the Ozempic label was updated to note it is not recommended in patients with severe gastroparesis; postmarketing reports also list ileus (intestinal blockage). A related concern is a rare risk of pulmonary aspiration during anesthesia, because food may remain in the stomach — so tell your care team you take Ozempic before any surgery or procedure with sedation.

Boxed warning: thyroid C-cell tumors

Semaglutide carries the FDA's strongest boxed warning for thyroid C-cell tumors, based on findings in rodents.

Whether this applies to humans is not known. Ozempic is contraindicated for anyone with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Report a lump in the neck, trouble swallowing, shortness of breath, or persistent hoarseness.

Hypoglycemia, kidney injury, retinopathy

On its own Ozempic carries a low hypoglycemia risk, but the risk rises sharply with insulin or a sulfonylurea — your clinician may adjust those.

Severe vomiting or diarrhea can lead to dehydration and acute kidney injury. Because Ozempic is used in type 2 diabetes, the label also flags possible diabetic retinopathy complications (keep recommended eye monitoring) and a modest increase in heart rate.

06

When to seek care: Ozempic red-flag table

Symptom / red flagWhat it may indicateWhat to do
Severe, persistent stomach pain (may spread to the back), ± vomitingPancreatitisStop Ozempic and seek urgent care
Upper-right abdominal pain, fever, jaundice, clay-colored stoolGallbladder disease / gallstonesContact your clinician promptly
Ongoing vomiting/diarrhea; can't keep fluids down; little urine, dizzinessDehydration → possible acute kidney injuryCall your clinician; seek care if severe
Severe constipation with bloating, cramping, and vomitingPossible bowel obstruction / ileusSeek medical evaluation
Lump in the neck, trouble swallowing, hoarseness, shortness of breathThyroid warning signContact your clinician
Shakiness, sweating, confusion, fast heartbeat (esp. with insulin/sulfonylurea)HypoglycemiaTreat low blood sugar; call your clinician
Rash, swelling of face/lips/throat, trouble breathingSerious allergic reactionCall emergency services

When in doubt, call your clinician or emergency services — this table is a guide, not a substitute for professional judgment.

07

Ozempic vs Wegovy side effects: the same molecule, different dose

Ozempic and Wegovy are both semaglutide, so they share the same side-effect profile. The differences are in dose and indication:

Ozempic (semaglutide)Wegovy (semaglutide)
Approved useType 2 diabetes; CV risk in T2DChronic weight management; CV risk reduction
Max weekly doseUp to 2 mgUp to 2.4 mg
Side-effect profileSame GI profileSame GI profile, often reported at higher rates
Boxed warningThyroid C-cell tumorsThyroid C-cell tumors

Because Wegovy titrates to a higher dose, gastrointestinal side effects are generally reported more often with Wegovy than Ozempic.

For the full breakdown, see our Wegovy side effects guide.

08

Practical ways to reduce Ozempic side effects

  1. Go slow. Follow the titration schedule; never rush to a higher dose on your own.
  2. Eat smaller, more frequent, lower-fat meals and stop at the first sign of fullness.
  3. Hydrate — sip water through the day, especially with any vomiting or diarrhea.
  4. Limit greasy, fried, very sweet, and heavily processed foods, which worsen nausea.
  5. Add fiber and move your body to counter constipation.
  6. Prioritize protein and gradual weight loss to protect muscle and reduce "Ozempic face."
  7. Track your symptoms, doses, and meals so patterns are visible for your next visit.
  8. Report red-flag symptoms immediately — don't "wait it out."

Because Ozempic side effects cluster around specific days and doses, a simple daily log of what you feel, when you dosed, and what you ate makes conversations with your clinician far more useful.

This is exactly what the Havit app is built to make effortless — log your dose, meals, and how you feel, and see your own patterns over time. (It's a tracking companion, not a medical device — always defer to your clinician.)

09

Why HAVIT — Medication + Behavior Change, in One App

GLP-1 medications can meaningfully reduce weight — but the number on the scale is only part of the story.

Roughly 20–40% of the weight lost on GLP-1 therapy can come from lean (muscle) tissue rather than fat (Neeland et al., Diabetes, Obesity and Metabolism, 2024), and results tend to fade once the medication stops unless new habits take their place.

That's why leading guidance treats medication as one part of care, not the whole: the U.S. Preventive Services Task Force recommends that adults with obesity be offered intensive, multicomponent behavioral interventions (USPSTF, Grade B).

HAVIT is built for exactly this moment — one app that unites medication tracking, body composition, nutrition and protein, daily habit-building, and an AI coach that adapts to you.

Across our own 1,090 GLP-1 users, the most consistent trackers built the strongest habits (see the GLP-1 habit report).

Manage the medicine and the muscle — together. Start with HAVIT →

The most common Ozempic side effects

Side effectOzempic 0.5 mgOzempic 1 mgPlacebo
Nausea15.8%20.3%6.1%
Vomiting5.0%9.2%2.3%
Diarrhea8.5%8.8%1.9%
Abdominal pain7.3%5.7%4.6%
Constipation3.1%5.0%1.5%

Frequently asked questions

What are the most common Ozempic side effects?
Gastrointestinal ones: nausea, vomiting, diarrhea, constipation, and abdominal pain. Per the FDA Ozempic label, nausea affected roughly 16–20% of patients (versus about 6% on placebo), and most GI symptoms occurred during dose escalation.
How long do Ozempic side effects last?
For most people they're temporary, usually easing within about 2 to 4 weeks of starting the drug or after each dose increase as the body adjusts. A slow dose ramp reduces both intensity and duration.
Why does Ozempic cause nausea?
It slows gastric emptying and acts on brain appetite centers, so food stays in the stomach longer and fullness signals increase — which can feel like nausea, especially early on and right after a dose.
What is "Ozempic face"?
It's a nickname, not a medical condition, for the gauntness, sunken cheeks, and loose skin that can follow rapid fat loss. It's caused by the pace of weight loss, not drug toxicity, and can happen with any fast weight loss.
What serious side effects should I watch for?
Pancreatitis (severe persistent abdominal pain), gallbladder disease/gallstones, severe delayed stomach emptying or bowel obstruction, dehydration-related kidney injury, hypoglycemia (especially with insulin or sulfonylureas), and serious allergic reactions. These need prompt care.
Do Ozempic side effects get worse at higher doses?
Yes — the label shows more nausea and vomiting at 1 mg than 0.5 mg. Side effects are dose-dependent, which is why a stepwise titration is used and most symptoms appear during dose increases.
Are Ozempic and Wegovy side effects the same?
They're the same molecule (semaglutide) with the same profile, but Wegovy titrates to a higher dose (2.4 mg vs up to 2 mg), so GI side effects are generally reported more often with Wegovy.
Do I need to tell my surgeon I take Ozempic?
Yes. Because it slows stomach emptying, there's a rare risk of aspiration under anesthesia. Tell your care team before any surgery or sedation so they can advise on timing.

What is Havit?

Havit is an AI health companion for weight loss that protects muscle.

Unlike calorie-only trackers, Havit connects AI body-composition estimates, nutrition, hydration, sleep, steps, cycle, mood, and GLP-1 medication in one daily routine — so progress is measured by body composition, not just the number on the scale. Daily missions turn established behavior-change techniques into small repeatable actions, drawing on expertise from professionals formerly at Juvis Diet, one of Korea’s leading metabolic clinics.

In Havit’s own analysis of 1,090 GLP-1 users, people who logged consistently built stronger habits than the general user base. Read the GLP-1 Habit Report

Havit works with or without GLP-1 medication. It is a wellness app, not a medical device; body-composition results are estimates.

HAVIT

Continue in the App

Personalized wellness with your own data

Download on the App StoreGet it on Google Play

References

  1. FDA — OZEMPIC (semaglutide) Prescribing Information (label). accessdata.fda.gov
  2. Ozempic.com (Novo Nordisk) — Possible Side Effects of Ozempic. ozempic.com
  3. Cleveland Clinic — "Ozempic Face": What It Is and How to Avoid It. health.clevelandclinic.org
  4. Cleveland Clinic — Can Certain Foods Impact Your Ozempic Side Effects? health.clevelandclinic.org
  5. FDA — Requests Removal of Suicidal Behavior and Ideation Warning from GLP-1 RA Medications (semaglutide safety context). fda.gov
  6. Pharmacy Times — FDA Adds Delayed Gastric Emptying as Adverse Event on Semaglutide Label. pharmacytimes.com
  7. All medical claims above were verified against the cited FDA Ozempic label, Novo Nordisk materials, and Cleveland Clinic as of mid-2026. Labels are updated periodically — confirm current details with your clinician and the official prescribing information.*

Related articles

Foundayo Side Effects: Nausea & Warnings (2026)
GLP-1 Dose Tracker: Log Your mg & Titration Schedule
GLP-1 Shot Tracker: Log Every Weekly Injection & Site
Injection Tracker App for GLP-1: Features to Look For

Ready for Smarter Weight Loss?

Everything you need to lose weight, preserve muscle, and build healthier habits—all in one AI-powered app.

Download on the App StoreGet it on Google Play

Free to download. In-app purchases may apply.